Pharming Group NV - ADRPHAR
13F holders, Q1 2024 (March 31)3holders
$10.50avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Pharming Group NV - ADR (PHAR) in their 13F filings. The largest holders were Silverberg Bernstein Capital Management LLC ($186K), Morgan Stanley ($29K) and UBS Group AG ($546).
- Company
- Pharming Group NV - ADR
- CUSIP
- 71716E105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $546 |
| Exits | 0 | $0 |
Ownership 3 holders
| Silverberg Bernstein Capital Management LLC | 0.18% | No change | 17,710 | $186K |
| Morgan Stanley | 0.00% | No change | 2,800 | $29K |
| UBS Group AG | 0.00% | New | 52 | $546 |
"% of holder's portfolio" is PHAR's weight in each manager's 13F, not the share of Pharming Group NV - ADR the manager owns.